Axsome Therapeutics
+$2.33 (+9.66%) Today
+$0.08 (+0.30%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.
About AXSM
Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 which are being developed for multiple pain and primary care indications.
CEO
Herriott Tabuteau
Employees
108
Headquarters
New York, New York
Founded
2012
AXSM Key Statistics
Market cap
1.03B
Price-Earnings ratio
—
Dividend yield
—
Average volume
775.48K
High today
$26.83
Low today
$23.28
Open price
$24.26
Volume
760.07K
52 Week high
$74.10
52 Week low
$19.38
Analyst ratings
80%
of 15 ratings
Buy
80%
Hold
13.3%
Sell
6.7%
AXSM Earnings
-$1.03
-$0.69
-$0.34
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, Pre-Market